RxDoctor Payments Data

Hallie Carter

Psychiatric/Mental Health · Tupelo, MSNPI 1770103053

Payments from drug & device makers

$2,717in general payments, 2019–2025

Across 173 payments — averaging $15.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
  • AbbVie$455
  • Pharmacyclics LLC, An Abbvie Company$228
  • Takeda Pharmaceuticals U.S.A., Inc.$206
  • Otsuka America Pharmaceutical, Inc.$173
  • Vanda Pharmaceuticals Inc.$143
  • plus $409 from 6 others

What the payments were for

  • Food & beverage$2,705100%
  • Education$120%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,717 in reported general payments places this provider in the 75th percentile of 486 psychiatric/mental health providers in Mississippi.

See all psychiatric/mental health providers in Mississippi

Medicare billing

Part B allowed, 2024
$189
Medicare patients
11
Services billed
16

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CaplytaLumateperone Tosylate31$63,206
VraylarCariprazine Hcl27$43,784
Vilazodone Hcl51$4,313
Buspirone Hcl77$973
Prazosin Hcl15$601
Quetiapine Fumarate25$464
Duloxetine Hcl28$436
Lamotrigine49$425
Atomoxetine Hcl11$408
Desvenlafaxine Succinate ErDesvenlafaxine Succinate11$363
Hydroxyzine Pamoate19$335
Bupropion XlBupropion Hcl16$319
Doxepin Hcl18$286
Paroxetine Hcl28$278
Escitalopram Oxalate15$268

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$1,104$63,20631 claims
AbbVieVraylar$455$43,78427 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 486 psychiatric/mental health providers in Mississippi.

Other psychiatric/mental health in Tupelo

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →